VKH
AGN.PRA

Virtu KCG Holdings’s Allergan plc AGN.PRA Stock Holding History

Virtu KCG Holdings’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-347
Closed -$357K – 4047
2015
Q4 		$357K Buy
+347
New +$349K 0.01% 1941

Other funds holding AGN.PRA

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $2.41B AUM 286.33% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Virtu KCG Holdings's AGN.PRA Position: Q1 2016 in Review

Virtu KCG Holdings sold out of Allergan plc (AGN.PRA) in Q1 2016, closing a stake of 347 shares — an estimated $357K sold.

Virtu KCG Holdings first reported a position in AGN.PRA in Q4 2015 and held it in 1 quarter. The position peaked at $357K in Q4 2015. 103 funds tracked by Wall St. Rank hold AGN.PRA as of Q1 2016.

  • Virtu KCG Holdings reported no remaining Allergan plc position as of Q1 2016 after selling out during the quarter.
  • Virtu KCG Holdings sold 347 Allergan plc shares in Q1 2016, an estimated $357K.
  • Virtu KCG Holdings first reported a position in Allergan plc in Q4 2015 and held it in 1 quarter.
  • Virtu KCG Holdings's Allergan plc position peaked at $357K in Q4 2015.
  • 103 funds tracked by Wall St. Rank held Allergan plc as of Q1 2016.

Based on Virtu KCG Holdings's 13F filing for Q1 2016, filed 13 May 2016.